Search hospitals

>

Michigan

>

Livonia

Trinity Health Saint Mary Mercy Livonia Hospital

Claim this profile

Livonia, Michigan 48154

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Cancer

Conducts research for Breast cancer

Conducts research for Non-Small Cell Lung Cancer

494 reported clinical trials

8 medical researchers

Photo of Trinity Health Saint Mary Mercy Livonia Hospital in LivoniaPhoto of Trinity Health Saint Mary Mercy Livonia Hospital in LivoniaPhoto of Trinity Health Saint Mary Mercy Livonia Hospital in Livonia

Summary

Trinity Health Saint Mary Mercy Livonia Hospital is a medical facility located in Livonia, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Trinity Health Saint Mary Mercy Livonia Hospital is involved with conducting 494 clinical trials across 494 conditions. There are 8 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.

Area of expertise

1

Lung Cancer

Global Leader

Trinity Health Saint Mary Mercy Livonia Hospital has run 93 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Breast Cancer

Global Leader

Trinity Health Saint Mary Mercy Livonia Hospital has run 88 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Trinity Health Saint Mary Mercy Livonia Hospital

Lung Cancer

Breast Cancer

Breast cancer

Prostate Cancer

Bladder Cancer

Cancer

Esophageal cancer

Kidney Cancer

Ovarian Cancer

Pancreatic Cancer

Image of trial facility.

Durvalumab

for Lung Cancer

This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.

Recruiting

2 awards

Phase 3

8 criteria

Image of trial facility.

Ceralasertib + Durvalumab

for Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.

Recruiting

2 awards

Phase 3

14 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Trinity Health Saint Mary Mercy Livonia Hospital?

Where is Trinity Health Saint Mary Mercy Livonia Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Trinity Health Saint Mary Mercy Livonia Hospital accept?

What awards or recognition has Trinity Health Saint Mary Mercy Livonia Hospital received?